Skip to main content

Table 3 Correlation coefficients between dL_RHI and clinical markers of glycemia and various nonglycemic metabolic variables

From: Effects of exenatide on postprandial vascular endothelial dysfunction in type 2 diabetes mellitus

  dAUC glucose dAUC IRI dAUC TG dAUC HDL dAUC LDL dCV glucose dCV IRI dCVTG TG dCV HDL dCV LDL
dAUCIRI −0.39          
dAUCTG −0.02 0.17         
dAUCHDL 0.40 0.33 -.0.06        
dAUCLDL −0.10 0.60* 0.04 0.35       
dCVglucose 0.06 0.39 −0.24 −0.12 0.50      
dCVIRI −0.43 0.58* 0.29 0.02 0.37 0.35     
dCVTG 0.39 0.09 −0.06 −0.13 0.27 0.37 0.14    
dCVHDL 0.44 −0.26 −0.23 −0.46 −0.09 −0.30 0.01 0.64*   
dCVLDL 0.35 0.35 −0.22 −0.42 −0.24 −0.24 −0.60* 0.14 0.38  
dL_RHI −0.37 0.33 0.24 0.16 −0.17 −0.19 0.29 −0.73** −0.61* −0.33
  1. Data are results of Spearman rank correlation. *P < 0.05, **P < 0.01.
  2. Abbreviations: dAUC change in the area under the curve, IRI Immunoreactive insulin, LDL low-density lipoprotein cholesterol, HDL high-density lipoprotein cholesterol, TG triglyceride, dCV change in the coefficient of variation, dL_RHI change in the natural logarithmic scaled reactive hyperemia index.